CA2551324C
(en)
|
2004-01-06 |
2012-11-27 |
Novo Nordisk A/S |
Heteroaryl-ureas and their use as glucokinase activators
|
EP1708697A4
(en)
*
|
2004-01-30 |
2007-11-28 |
Smithkline Beecham Corp |
CHEMICAL COMPOUNDS
|
CA2560454C
(en)
*
|
2004-03-30 |
2013-05-21 |
Vertex Pharmaceuticals Incorporated |
Azaindoles useful as inhibitors of jak and other protein kinases
|
JPWO2006001318A1
(ja)
*
|
2004-06-24 |
2008-07-31 |
塩野義製薬株式会社 |
スルホンアミド化合物
|
CA2572058A1
(en)
*
|
2004-06-30 |
2006-01-12 |
Vertex Pharmaceuticals Incorporated |
Azaindoles useful as inhibitors of protein kinases
|
MX2007000092A
(es)
*
|
2004-06-30 |
2007-03-07 |
Vertex Pharma |
Azaindoles utiles como inhibidores de proteinas cinasas.
|
WO2006020767A2
(en)
*
|
2004-08-13 |
2006-02-23 |
Genentech, Inc. |
Thiazole based inhibitors of atp-utilizing enzymes
|
CA2587894A1
(en)
*
|
2004-11-22 |
2006-06-01 |
Vertex Pharmaceuticals Incorporated |
Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases
|
US20090264650A1
(en)
*
|
2005-03-31 |
2009-10-22 |
Nobuo Cho |
Prophylactic/Therapeutic Agent for Diabetes
|
CN101228161B
(zh)
*
|
2005-05-20 |
2012-10-10 |
沃泰克斯药物股份有限公司 |
适用作蛋白激酶抑制剂的吡咯并吡啶类
|
EP1904466A1
(en)
|
2005-07-08 |
2008-04-02 |
Novo Nordisk A/S |
Dicycloalkyl urea glucokinase activators
|
JP4960355B2
(ja)
*
|
2005-07-14 |
2012-06-27 |
ノボ・ノルデイスク・エー/エス |
ウレア型グルコキナーゼ活性化剤
|
EP1922306A2
(en)
|
2005-09-02 |
2008-05-21 |
Astellas Pharma Inc. |
Amide derivatives as rock inhibitors
|
US7592461B2
(en)
|
2005-12-21 |
2009-09-22 |
Bristol-Myers Squibb Company |
Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
|
WO2007076423A2
(en)
*
|
2005-12-22 |
2007-07-05 |
Smithkline Beecham Corporation |
INHIBITORS OF Akt ACTIVITY
|
WO2007084557A2
(en)
|
2006-01-17 |
2007-07-26 |
Vertex Pharmaceuticals Incorporated |
Azaindoles useful as inhibitors of janus kinases
|
WO2007082808A2
(en)
*
|
2006-01-18 |
2007-07-26 |
F. Hoffmann-La Roche Ag |
Thiazoles as 11 beta-hsd1 inhibitors
|
US7915305B2
(en)
|
2006-01-23 |
2011-03-29 |
Vertex Pharmaceuticals Incorporated |
Thiophene-carboxamides useful as inhibitors of protein kinases
|
WO2007089548A2
(en)
*
|
2006-01-26 |
2007-08-09 |
Foldrx Pharmaceuticals, Inc. |
Compounds and methods for modulating protein trafficking
|
KR20090018895A
(ko)
*
|
2006-04-05 |
2009-02-24 |
버텍스 파마슈티칼스 인코포레이티드 |
야누스 키나제의 억제제로서 유용한 데아자푸린
|
AU2007238698A1
(en)
|
2006-04-13 |
2007-10-25 |
Vertex Pharmaceuticals Incorporated |
Thiophene-carboxamides useful as inhibitors of protein kinases
|
CN101495474A
(zh)
|
2006-05-23 |
2009-07-29 |
沃泰克斯药物股份有限公司 |
可用作蛋白激酶抑制剂的噻吩-甲酰胺类
|
US8853244B2
(en)
|
2006-05-23 |
2014-10-07 |
Vertex Pharmaceuticals Incorporated |
Thiophene-carboxamides useful as inhibitors of protein kinases
|
FR2907120B1
(fr)
|
2006-10-12 |
2013-01-11 |
Sanofi Aventis |
Nouveaux derives imidazolones,leur preparation a titre de medicaments,compositions pharmaceutiques,utilisation comme inhibiteurs de proteines kinases notamment cdc7
|
WO2008063888A2
(en)
|
2006-11-22 |
2008-05-29 |
Plexxikon, Inc. |
Compounds modulating c-fms and/or c-kit activity and uses therefor
|
US8247421B2
(en)
|
2006-12-21 |
2012-08-21 |
Vertex Pharmaceuticals Incorporated |
5-cyano-4-(pyrrolo [2,3B] pyridine-3-yl)-pyrimidine derivatives useful as protein kinase inhibitors
|
WO2008079909A1
(en)
*
|
2006-12-21 |
2008-07-03 |
Plexxikon, Inc. |
Pyrrolo [2,3-b] pyridines as kinase modulators
|
US8318778B2
(en)
|
2007-01-11 |
2012-11-27 |
Novo Nordisk A/S |
Urea glucokinase activators
|
GB0702259D0
(en)
*
|
2007-02-06 |
2007-03-14 |
Eisai London Res Lab Ltd |
7-azaindole derivatives
|
WO2008112297A2
(en)
*
|
2007-03-13 |
2008-09-18 |
Yale University |
Methods of treating cancer by interfering with igf-i receptor signaling
|
CN101808994B
(zh)
|
2007-07-17 |
2013-05-15 |
普莱希科公司 |
用于激酶调节的化合物和方法以及其适应症
|
KR20150088907A
(ko)
|
2007-08-29 |
2015-08-03 |
센주 세이야꾸 가부시키가이샤 |
각막 내피 세포 접착 촉진제
|
CL2009001152A1
(es)
|
2008-05-13 |
2009-10-16 |
Array Biopharma Inc |
Compuestos derivados de n-(4-(cicloalquilo nitrogenado-1-il)-1h-pirrolo[2,3-b]piridin-3-il)amida, inhibidores de cinasa; proceso de preparacion; composicion farmaceutica; y su uso para el tratamiento de una enfermedad proliferativa.
|
US20110160255A1
(en)
*
|
2008-06-26 |
2011-06-30 |
Rouse Meagan B |
Inhibitors of akt activity
|
WO2009158373A1
(en)
*
|
2008-06-26 |
2009-12-30 |
Smithkline Beecham Corporation |
Inhibitors of akt activity
|
GB0812648D0
(en)
*
|
2008-07-10 |
2008-08-20 |
Prosidion Ltd |
Compounds
|
PE20110105A1
(es)
|
2008-07-15 |
2011-02-25 |
Novartis Ag |
Derivados de heteroarilo como inhibidores de dgat1
|
EP2318408B1
(en)
*
|
2008-07-23 |
2016-02-17 |
Vertex Pharmaceuticals Incorporated |
Tri-cyclic pyrazolopyridine kinase inhibitors
|
NZ590784A
(en)
|
2008-07-23 |
2012-12-21 |
Vertex Pharma |
Pyrazolopyridine kinase inhibitors
|
MX2011000834A
(es)
*
|
2008-07-23 |
2011-04-05 |
Vertex Pharma |
Inhibidores de pirazolopiridin cinasa.
|
EP2328896B1
(en)
*
|
2008-07-23 |
2013-10-23 |
Vertex Pharmaceuticals Incorporated |
Tri-cyclic pyrazolopyridine kinase inhibitors
|
DE102008038221A1
(de)
|
2008-08-18 |
2010-02-25 |
Merck Patent Gmbh |
7-Azaindolderivate
|
US8193372B2
(en)
*
|
2009-03-04 |
2012-06-05 |
Idenix Pharmaceuticals, Inc. |
Phosphothiophene and phosphothiazole HCV polymerase inhibitors
|
US9447089B2
(en)
|
2009-04-03 |
2016-09-20 |
Plexxikon Inc. |
Compositions and uses thereof
|
EP2427464A1
(en)
|
2009-05-06 |
2012-03-14 |
Vertex Pharmaceuticals Incorporated |
Pyrazolopyridines
|
CN104940202B
(zh)
|
2009-06-17 |
2018-10-16 |
沃泰克斯药物股份有限公司 |
流感病毒复制抑制剂
|
US8329724B2
(en)
|
2009-08-03 |
2012-12-11 |
Hoffmann-La Roche Inc. |
Process for the manufacture of pharmaceutically active compounds
|
EA201290073A1
(ru)
|
2009-08-24 |
2013-01-30 |
Эсэпиен Фармасьютикалз, Инк. |
Соединения мочевины, содержащие 5,6-бициклический гетероарил, как ингибиторы киназ
|
UA105813C2
(uk)
|
2009-11-06 |
2014-06-25 |
Плексікон, Інк. |
Сполуки-інгібітори кіназ та фармацевтична композиція (варіанти)
|
DE102009058280A1
(de)
*
|
2009-12-14 |
2011-06-16 |
Merck Patent Gmbh |
Thiazolderivate
|
AU2011209649A1
(en)
|
2010-01-27 |
2012-08-09 |
Vertex Pharmaceuticals Incorporated |
Pyrazolopyrazine kinase inhibitors
|
JP2013518114A
(ja)
|
2010-01-27 |
2013-05-20 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
ピラゾロピリミジンキナーゼ阻害剤
|
JP5769733B2
(ja)
|
2010-01-27 |
2015-08-26 |
バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated |
ピラゾロピリジンキナーゼ阻害剤
|
US9133123B2
(en)
|
2010-04-23 |
2015-09-15 |
Cytokinetics, Inc. |
Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
|
AR081331A1
(es)
|
2010-04-23 |
2012-08-08 |
Cytokinetics Inc |
Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
|
AR081626A1
(es)
|
2010-04-23 |
2012-10-10 |
Cytokinetics Inc |
Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
|
US8877794B2
(en)
*
|
2010-08-13 |
2014-11-04 |
Abbott Laboratories |
Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
CN103492381A
(zh)
|
2010-12-16 |
2014-01-01 |
沃泰克斯药物股份有限公司 |
流感病毒复制的抑制剂
|
AU2012214762B2
(en)
|
2011-02-07 |
2015-08-13 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
TWI558702B
(zh)
|
2011-02-21 |
2016-11-21 |
普雷辛肯公司 |
醫藥活性物質的固態形式
|
US8759380B2
(en)
|
2011-04-22 |
2014-06-24 |
Cytokinetics, Inc. |
Certain heterocycles, compositions thereof, and methods for their use
|
UA118010C2
(uk)
|
2011-08-01 |
2018-11-12 |
Вертекс Фармасьютікалз Інкорпорейтед |
Інгібітори реплікації вірусів грипу
|
DE102011083283A1
(de)
*
|
2011-09-23 |
2013-03-28 |
Beiersdorf Ag |
Heteroalkylamidothiazole, deren kosmetische oder dermatologische Verwendung sowie kosmetische oder dermatologische Zubereitungen mit einem Gehalt an solchen Heteroalkylamidothiazolen
|
PT2788472T
(pt)
|
2011-12-06 |
2019-04-01 |
Astellas Inst For Regenerative Medicine |
Método de diferenciação dirigida para a produção de células endoteliais corneanas
|
EP3553169B1
(en)
|
2011-12-28 |
2021-11-03 |
Kyoto Prefectural Public University Corporation |
Normalization of culture of corneal endothelial cells
|
US9150570B2
(en)
|
2012-05-31 |
2015-10-06 |
Plexxikon Inc. |
Synthesis of heterocyclic compounds
|
CN104603118B
(zh)
|
2012-05-31 |
2017-10-03 |
菲尼克斯药品股份公司 |
作为孤儿核受体RORγ调节物的经甲酰胺或磺酰胺取代的噻唑及相关衍生物
|
JP6189948B2
(ja)
|
2012-06-29 |
2017-08-30 |
ファイザー・インク |
LRRK2阻害薬としての新規な4−(置換アミノ)−7H−ピロロ[2,3−d]ピリミジン
|
WO2014177699A1
(en)
*
|
2013-05-03 |
2014-11-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Rhoa (rock) inhibitors for the treatment of enflammatory bowel disease
|
JP6548576B2
(ja)
|
2013-07-30 |
2019-07-24 |
京都府公立大学法人 |
角膜内皮細胞マーカー
|
EP3804760A1
(en)
|
2013-10-31 |
2021-04-14 |
Kyoto Prefectural Public University Corporation |
Therapeutic drug for diseases related to endoplasmic reticulum cell death in corneal endothelium
|
PL3068782T3
(pl)
|
2013-11-13 |
2018-12-31 |
Vertex Pharmaceuticals Incorporated |
Sposoby wytwarzania inhibitorów replikacji wirusów grypy
|
NZ719729A
(en)
|
2013-11-13 |
2022-04-29 |
Vertex Pharma |
Inhibitors of influenza viruses replication
|
CA2931280A1
(en)
|
2013-11-27 |
2015-06-04 |
Senju Pharmaceutical Co., Ltd. |
Application of laminin to corneal endothelial cell culture
|
US9695171B2
(en)
|
2013-12-17 |
2017-07-04 |
Pfizer Inc. |
3,4-disubstituted-1 H-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7H-pyrrolo[2,3-c]pyridazines as LRRK2 inhibitors
|
TWI652265B
(zh)
|
2014-02-04 |
2019-03-01 |
大鵬藥品工業股份有限公司 |
氮雜吲哚衍生物
|
WO2016026078A1
(en)
*
|
2014-08-19 |
2016-02-25 |
Changzhou Jiekai Pharmatech Co., Ltd. |
Heterocyclic compounds as erk inhibitors
|
AU2015315177A1
(en)
*
|
2014-09-10 |
2017-03-16 |
Epizyme, Inc. |
Substituted pyrrolidine carboxamide compounds
|
JP6704416B2
(ja)
|
2015-05-13 |
2020-06-03 |
バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated |
インフルエンザウイルスの複製の阻害剤を調製する方法
|
MA42422A
(fr)
|
2015-05-13 |
2018-05-23 |
Vertex Pharma |
Inhibiteurs de la réplication des virus de la grippe
|
RU2722149C1
(ru)
|
2015-09-14 |
2020-05-27 |
Пфайзер Инк. |
Новые производные имидазо[4,5-c] хинолинов и имидазо[4,5-c][1,5] нафтиридинов в качестве ингибиторов LRRK2
|
EP4088719A1
(en)
|
2015-10-13 |
2022-11-16 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Methods and pharmaceutical compositions for the treatment of retinal capillary non-perfusion
|
US12048761B2
(en)
|
2015-10-13 |
2024-07-30 |
Inserm (Institut National De La Santé Et De La Recherche Medicale) |
Methods and pharmaceutical compositions for the treatment of retinal capillary non-perfusion
|
JP7008337B2
(ja)
|
2016-02-15 |
2022-02-10 |
京都府公立大学法人 |
ヒト機能性角膜内皮細胞およびその応用
|
CN108203433B
(zh)
*
|
2016-12-16 |
2020-07-03 |
成都先导药物开发股份有限公司 |
一种rock抑制剂及其应用
|
CN108948002A
(zh)
|
2017-05-19 |
2018-12-07 |
厦门大学 |
五元并六元氮杂芳环类化合物、其制备方法、药用组合物及其应用
|
ES2841951T3
(es)
*
|
2018-04-17 |
2021-07-12 |
Univ Masarykova |
Propanamidas sustituidas como inhibidores de nucleasas
|
EP3806852A1
(en)
|
2018-06-12 |
2021-04-21 |
vTv Therapeutics LLC |
Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs
|
WO2020045642A1
(ja)
|
2018-08-31 |
2020-03-05 |
学校法人同志社 |
眼細胞を保存または培養するための組成物および方法
|
AU2019352309A1
(en)
|
2018-10-02 |
2021-03-11 |
The Doshisha |
Method and vessel for preserving corneal endothelial cells
|
AU2019381808A1
(en)
*
|
2018-11-16 |
2021-05-27 |
1200 Pharma Llc |
ERK inhibitors and uses thereof
|
US11174263B2
(en)
|
2018-12-31 |
2021-11-16 |
Biomea Fusion, Inc. |
Inhibitors of menin-MLL interaction
|
BR112021011578A2
(pt)
|
2018-12-31 |
2021-08-31 |
Biomea Fusion, Llc |
Inibidores irreversíveis de interação menina-mll
|
WO2021064141A1
(en)
*
|
2019-10-02 |
2021-04-08 |
Tolremo Therapeutics Ag |
Inhibitors of dual specificity tyrosine phosphorylation regulated kinase 1b
|
BR112022017180A2
(pt)
|
2020-02-27 |
2022-10-18 |
Kyoto Prefectural Public Univ Corp |
Células endoteliais da córnea humanas funcionais e aplicação das mesmas
|
CN115916776A
(zh)
*
|
2020-06-09 |
2023-04-04 |
艾尼莫生物科技公司 |
胶原蛋白1翻译抑制剂及其使用方法
|
WO2022235586A1
(en)
|
2021-05-03 |
2022-11-10 |
Astellas Institute For Regenerative Medicine |
Methods of generating mature corneal endothelial cells
|
JP2024534014A
(ja)
|
2021-08-20 |
2024-09-18 |
バイオメア フュージョン,インコーポレイテッド |
癌の処置のための不可逆的メニン-MLL阻害剤、N-[4-[4-(4-モルホリニル)-7H-ピロロ[2,3-d]ピリミジン-6-イル]フェニル]-4-[[3(R)-[(1-オキソ-2-プロペン-1-イル)アミノ]-1-ピペリジニル]メチル]-2-ピリジンカルボキサミドの結晶形態
|
WO2023085369A1
(ja)
|
2021-11-11 |
2023-05-19 |
学校法人同志社 |
角膜内皮細胞の凍結保存製剤およびその製造法
|